相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Pharmacokinetics of nelfinavir in HIV-1-infected pregnant and nonpregnant women
P. Villani et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2006)
Maternal hepatotoxicity with nevirapine as part of combination antiretroviral therapy in pregnancy
F Lyons et al.
HIV MEDICINE (2006)
Is antiretroviral therapy during pregnancy associated with an increased risk of preterm delivery, low birth weight, or stillbirth?
AM Cotter et al.
JOURNAL OF INFECTIOUS DISEASES (2006)
Comparison of nevirapine (NVP) resistance in Ugandan women 7 days vs. 6-8 weeks after single-dose NVP prophylaxis: HIVNET 012
SH Eshleman et al.
AIDS RESEARCH AND HUMAN RETROVIRUSES (2004)
Pharmacokinetics of nelfinavir and indinavir in HIV-1-infected pregnant women
BW Kosel et al.
AIDS (2003)
Two-dose intrapartum/newborn nevirapine and standard antiretroviral therapy to reduce perinatal HIV transmission - A randomized trial
A Dorenbaum et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2002)
Virologic response to nelfinavir-based regimens: pharmacokinetics and drug resistance mutations (VIRAPHAR study)
I Pellegrin et al.
AIDS (2002)
Analysis of variation in plasma concentrations of nelfinavir and its active metabolite M8 in HIV-positive patients
PA Baede-van Dijk et al.
AIDS (2001)
Nevirapine - Pharmacokinetic considerations in children and pregnant women
M Mirochnick et al.
CLINICAL PHARMACOKINETICS (2000)